SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

StarkNet is a permissionless decentralized Layer 2 (L2) validity rollup, built to allow Ethereum to scale via cryptographic protocols called STARKs, without compromising Ethereum’s core principles of decentralization, transparency, inclusivity and security. The StarkNet Token is needed to operate the ecosystem, maintain and secure it, decide on its values and strategic goals, and direct its evolution. This token will be required for (i) governance, (ii) payment of transaction fees on StarkNet, and (iii) participation in StarkNet’s consensus mechanism.

Starknet

STRKs sharp rally is drawing attention amid Starknets privacy push, including strkBTC, a Bitcoin wrapper with optional shielding, and the planned expansion of privacy features to other tokens. Traders are upbeat about the Bitcoin DeFi and privacy themes and rising volume, while others question whether the move can hold and point to token-unlock pressure.

Bittensor is an open-source protocol that powers a decentralized, blockchain-based machine learning network. Machine learning models train collaboratively and are rewarded in TAO according to the informational value they offer the collective. TAO also grants external access, allowing users to extract information from the network while tuning its activities to their needs.  Ultimately, BitTensors vision is to create a pure market for artificial intelligence, an incentivized arena in which consumers and producers of this valuable commodity can interact in a trustless, open and transparent context.  Bittensor enables:  -A novel, optimized strategy for the development and distribution of artificial intelligence technology by leveraging the possibilities of a distributed ledger. Specifically, its facilitation of open access/ownership, decentralized governance, and the ability to harness globally-distributed resources of computing power and innovation within an incentivized framework.  -An open-source repository of machine intelligence, accessible to anyone, anywhere, thus creating the conditions for open and permission-less innovation on a global internet scale.  -Distribution of rewards and network ownership to users in direct proportion to the value they have added.

Bittensor

TAO is drawing attention amid a price rebound, with traders discussing entry points and renewed interest in Bittensors decentralized-AI theme. Some link the move to a broader AI-token rally and speculate that China could ease crypto restrictions, but that claim is unconfirmed; others remain cautious about volatility.

Zillow Group, Inc. engages in the provision of real estate and home-related information marketplaces on mobile and the web. The company was founded by Richard N. Barton and Lloyd D. Frink in December 2004 and is headquartered in Seattle, WA.

Zillow Group Inc - Ordinary Shares - Class C

Zillow Group Inc Class C

Zillows steep selloff is being tied to reduced residential outlook in its latest earnings update, alongside persistent pressure from high mortgage rates and weak housing activity. Traders are split between calling the shares oversold and fearing further declines, with some blaming the broader housing slowdown and others pointing to company-specific guidance and execution concerns.

VanEck ETF Trust - VanEck Gold Miners ETF

VanEck Gold Miners ETF

Golds pullback and concerns that elevated yields and Fed rate-hike risks will weigh on bullion are driving debate around GDX. Traders are split between expecting more downside in the correction and buying for a rebound, with longer-term bulls pointing to debt concerns and central-bank gold demand.

Coca-Cola Company (The). The Group's principal activities are manufacturing, distributing and marketing nonalcoholic beverage concentrates and syrups. The products of the Group include carbonated soft drinks and also various kinds of non carbonated beverages. The Group sells these beverages, concentrates and syrups to bottling and canning operations, distributors, fountain wholesalers and retailers. The other products marketed and distributed by the Group include juice drinks, sports drinks, water products, teas, coffees and other beverage products. The Group also has ownership interests in various canning and bottling operations. The operations of the Group are conducted in the United States, Europe, Eurasia, Middle East, Africa, Latin America and Asia.

Coca-Cola Co

Coca-Colas stronger-than-expected second-quarter results and raised full-year outlook, supported by higher beverage volumes, are driving attention around its rally to record highs. Many traders view KO as a resilient defensive holding, while others argue the stocks elevated valuation and sharp run-up leave it vulnerable to a pullback.

BNB is the native utility token of the BNB Chain ecosystem, acting as a multi-chain asset that powers decentralized applications and facilitates value exchange across its network. It serves as the primary asset for paying transaction gas and smart contract deployment fees while providing users with tiered fee discounts on the Binance exchange. The project’s main value proposition lies in its unified multi-chain architecture, which integrates a smart contract platform, a Layer 2 scaling solution, and a decentralized data storage network into a cohesive settlement and data availability layer.  The network operates on a Proof of Staked Authority consensus mechanism, utilizing a group of 21 active validators known as the Cabinet to verify transactions and produce blocks every 3 seconds. Validators are elected daily based on the amount of BNB staked or delegated to them, and the system employs fast finality and slashing penalties to maintain security and integrity. To manage its long-term economy, the project uses a programmatic dual-burn strategy that permanently removes tokens through real-time fee destruction and quarterly buybacks.  Launched in 2017 by the Binance platform, the project initially distributed 50% of its 200 million token supply to the public, while the founding team received 40% and angel investors were allocated 10%. Though it began as a token on the Ethereum network, it eventually migrated to its own autonomous architecture that remains fully compatible with the Ethereum Virtual Machine. Today, the token's utility includes paying for network gas, participating in staking rewards, and enabling decentralized governance through which holders can vote on technical upgrades and economic changes.

Binance

BNB is drawing attention for choppy consolidation after a rebound, with traders sharing technical setups and debating whether it can break resistance or retreat toward support. Bullish calls tied to broader crypto optimism contrast with concerns that BNB has been weak and the move may fade.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEARs confidential perpetual-futures launch with Hyperliquid is the main catalyst traders cite for the sharp rally, drawing fresh attention to its privacy and AI-agent infrastructure story. The conversation is largely bullish, though some traders caution against chasing the surge and expect a pullback.

Sigma Lithium Corp. engages in the producing of a lithium property. It focuses its project in Minas Gerais. The firm also plans to build a world-class commercial-scale lithium concentration plant. The company was founded on June 8, 2011 and is headquartered in Sao Paulo, Brazil.

Sigma Lithium Corporation

A Brazilian federal appeals court restored key environmental licenses, allowing Sigma Lithium to resume mining and industrial operations at Grota do Cirilo. Traders welcomed the restart, but the expansion remains blocked pending further review, leaving debate over ongoing permitting risk and execution.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Traders are comparing Zevras Niemann-Pick franchise with IntraBios reported $2 billion sale, arguing the deal highlights potential value in ZVRA and fueling buyout speculation amid the stocks recent rise. Others caution that the companies assets and growth prospects differ, and that European approval and competition remain uncertainties.

RH operates as a holding company which operates the business through its subsidiary Restoration Hardware, Inc. It offers furniture, lighting, textiles, bath ware, decor, outdoor and garden, as well as baby and child products. The company operates an integrated business with multiple channels of distribution including galleries, source books and websites. The company was founded by Stephen J. Gordon in 1980 and is headquartered in Corte Madera, CA.

RH - Ordinary Shares - Class A

Restoration Hardware

RH is drawing attention after a mixed Q2 earnings report and updated outlook; traders are debating whether the strong adjusted earnings result reflects improving business momentum or was materially helped by tariff refunds, with concerns about underlying demand and debt. Bears expect further weakness, while some bulls see the selloff as a buying opportunity and point to potential short-squeeze interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Top stocks in news: Fractal, Manappuram, Aye, Ola Electric, AEL, GMR Airports, Auro Pharma

… Clothing, Saven Technologies, Aarti Pharmalabs , Kesar Terminals & … in Pune. Aurobindo Pharma : The pharma company’s subsidiary, … Zydus Lifesciences: The pharma company has received … operating models. Akums Drugs and Pharmaceuticals : The drugmaker reported …

Akums Drugs posts ₹1,160 Cr in Q3 FY26

Mumbai: CDMO Akums Drugs and Pharmaceuticals posted a revenue of Rs … Sanjeev Jain, MD, Akums Drugs and Pharmaceuticals . Published On Feb 14, 2026 …

Mars Appoints Manish Syag as Managing Director for its Pet Nutrition Business in India

New Delhi [India], February 14: Today, Mars, Incorporated announced the appointment of Manish Syag as Managing Director of its Pet Nutrition division in India. Manish will lead the business, home to some of the country's most trusted and pioneering pet food brands, including PEDIGREE®, WHISKAS®, SHEBA®, among others.

ETRe-Pharma Summit to Spotlight the Innovation Reckoning Reshaping India’s Pharma Future

… Equirus Capital, Akums Drugs and Pharmaceuticals Limited, METTLER … ); Praveen Rao Akkinepally ( AstraZeneca India); Dr. Mahesh … Emcure Pharmaceuticals Limited, exploring: Women in Pharma — From … and Ganpat Anchaliya ( Novartis Corporate Center, Hyderabad). …

India to Host the Eighteenth Edition of South Asia’s Largest Pharma Event

… showcase the complete pharmaceutical value chain— … Pharma Leaders Roundtable *Women in Pharma Roundtable *CPHI Pharma Awards * Pharma … Exhibit Top pharmaceutical companies participating … Oceanic Pharmachem , and Akums Drugs and Pharmaceuticals . Others …

SC Drops Criminal Charges Against P&G Director, But No Relief For Akums Drugs in Vicks Gel Case

… alleged distribution of expired drugs in Mumbai. The case … drug, manufactured by Akums Drugs and Pharmaceuticals and distributed by P … , including local distributors, Akums Drugs , P&G Ltd., … role in distribution of the drugs without supporting material. The …

Trading Radar For August 25: Yes Bank, Reliance Group, IDBI Bank, Titagarh Rail And Akums Drugs Shares On Investors’ Watchlist

Equity

InterGlobe Aviation and Max Healthcare Institute to replace Hero MotoCorp and IndusInd Bank in the Nifty 50 index, effective Sept. 30

Akums Reports Q1 FY26 with 19% YoY Adj EBITDA Growth; Achieves 1,000 DCGI Approvals

New Delhi [India], August 9: Akums Drugs and Pharmaceuticals Ltd., India's largest contract development and manufacturing organization (CDMO), has announced its consolidated financial results for the quarter ended June 30, 2025. This quarter continued to display strong performance with healthy growth in Adj EBITDA and Adj PAT.

Mars and Instamart Expand Paw Protecc to Hyderabad and Chennai to Shield Homeless Pets from Monsoon Hardship

New Delhi, Delhi, India (NewsVoir) As the monsoon rains sweep across India, Mars, Incorporated, a global leader in pet care products and services and Instamart – India’s pioneering quick-commerce platform – have expanded their joint initiative, PAW PROTECC, to support homeless pets. PAW PROTECC is a first-of-its-kind intervention that installs mobile shelters exclusively built for […]

NPPA allows Torrent Pharma to make combination drug in its own site at same retail price

… NPPA) has allowed Torrent Pharmaceuticals to shift manufacturing facility for … at Sikkim from Akums Drugs and Pharmaceuticals Ltd. "The … instant case since Torrent Pharmaceuticals Ltd has applied for … , it noted. The drugs price regulator modified the …

Akums Drugs & Pharmaceuticals Ltd. engages in the manufacturing and marketing of pharmaceutical products and services. It operates through the following segments: Contract Development and Manufacturing Operations (CDMO), Active Pharmaceutical Ingredient (API), Domestic Branded Formulations, International Branded Formulations, and Trade Generics. The CDMO segment manages the formulation of research and development, preparation and regulatory filing of dossiers, manufacturing formulations on contract basis, job work and testing services. The API segment offers the manufacturing and sale of KSM, Intermediate, and API products. The Domestic Branded Formulations segment refers to the marketing of its branded formulations in the Indian market. The International Branded Formulation segment deals with the marketing of its branded formulations in the global market. The Trade Generic segment is involved in the supply its generic products in the Indian market. The company was founded by Sanjeev Jain and Sandeep Jain on April 19, 2004 and is headquartered in New Delhi, India.

Current Price	749.65
Prev Close	784.90
Open	780.80
Dividend Yield	0.21%
50-Day Moving Average	767.73
Beta	0.42
Avg. Volume	327,710.33
PE Ratio	39.46

52-Week High	848.00
52-Week Low	408.02
Market Capitalization	118.21B
EPS (Annual)	16.67
Price to Book	3.47
Revenue Per Employee	2.42M

Feed

News

Sentiment

Fundamentals

Info

AKUMS.NSE Fundamentals